Lilly's VERVE-102 reduces cholesterol by up to 62% in phase 1b trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. CBRS
2. QCOM
3. FDX
4. USO
5. KBH
6. HTZ
7. SPY
8. HON
9. PFE
10. SPCX

Go back to Lilly's VERVE-102 reduces cholesterol by up to 62% in phase 1b trial
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 1112.08 +5.00 (0.45%)
Previous Close $1107.08    52 Week High $88.16 
Open $1129.41    52 Week Low $67.88 
Day High $1135.14    P/E 257.43 
Day Low $1100.98    EPS $4.32 
Volume 1,713,618